Selective Serotonin Reuptake Inhibitors may Influence COVID-19 Prognosis through Antioxidant and Cytoprotective Pathways Mediated by Sigma 1 Receptor Agonism.

JSON

Papadopoulos KI, Papadopoulou A, Aw TC

Pharmacopsychiatry - (-) - [2022-08-18; online 2022-08-18]

Category: Health

Type: Journal article

PubMed 35981550

DOI 10.1055/a-1909-2198

Crossref 10.1055/a-1909-2198